Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab
토실리주맙으로 치료받은 중증 코로나19 환자의 폐혈관 개선
Observational Study
[키워드] addition
alveolar
Alveolar-arterial oxygen gradient
anti-IL-6 receptor
CAR-T
CAR-T cell therapy
Cell therapy
Chest-X ray
clinical
compassionate-use therapies
contrary
controls
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19 patients
cytokine
Cytokine release syndrome
develop
explain
Hyperinflammatory syndrome
IL-6
immunomodulatory
Inflammatory marker
inflammatory markers
intensive care
limitations
management
monoclonal antibody
observational study
occur
off-label
oxygen
parameter
Patient
pulmonary
radiologic
receiving
respiratory status
retrospective
severe COVID-19
severe COVID-19 patient
Standard-of-care
suggested
supportive care
therapy
Tocilizumab
tocilizumab -
tocilizumab administration
treated
Treatment
Vascular
Vascular score.
worsened
[DOI] 10.1016/j.imlet.2020.10.009 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.imlet.2020.10.009 PMC 바로가기 [Article Type] Observational Study